Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Çѱ¹ÀÎÀÇ ¸¸¼º °£¿°°ú °£ °æº¯Áõ¿¡¼­ÀÇ Ç× ÆòÈ°±Ù Ç×ü ¹× Ç× ÇÙ Ç×üÀÇ ÃâÇöºóµµ Study on the Anti-Smooth Muscle Antibody and Anti-Nuclear Antibody of Chronic Active Hepatitis, Chronic Persistant Heratitis and Liver Cirrhosis in Korea

´ëÇѺ´¸®ÇÐȸÁö 1986³â 20±Ç 2È£ p.147 ~ 156
ÀÌ°©³ë, ¹é½Â·æ, ÀÌ»ó±¹,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌ°©³ë (  ) 
°í·Á´ëÇб³ ÀÓ»óº´¸®Çб³½Ç

¹é½Â·æ (  ) 
°í·Á´ëÇб³ ÀÓ»óº´¸®Çб³½Ç
À̻󱹠(  ) 
¼­¿ï´ëÇб³ º´¸®Çб³½Ç

Abstract

In Korea chronic liver diseases are the important medical issues because of their high
incidence, poor prognosis and no available therapeutic resume. It is believed that the
etiologic agent of most of chronic liver diseases in Korea is hepatitis B virus.
To find out the incidence of positivity and to understand the autoantibodies in some of
the chronic liver diseases in Korea, anti-smooth muscle antibody and anti-nuclear
antibody tests were performed on 43 patient serum with chronic active hepatitis, 13
patient serum with chronic persistant hepatitis and 20 patient serum with liver cirrhosis,
who diagnosed by liver biopsies.
The results of the study are summarized as follows:
1) The positivity of anti-smooth muscle antibody in chronic active hepatitis was 93.0%,
that in chronic persistant hepatitis 60.0% and that in liver cirrhosis 80.0%.
2) The positivity of anti¡¤nuclear antibody in chronic active hepatitis was 18.6%, that
in chronic persistent hepatitis 15.4%, that in liver cirrhosis 5.0%.
3) The test efficiency of anti-smooth muscle antibody to differentiate chronic active
hepatitis from chronic persistant hepatitis and liver cirrhosis was 48.7%
The above results suggest that the antismooth muscle antibody may be related to the
"necrosis of liver cells", and further studies are needed to fine out any relationship
between the autoantibody and the disturbance of immune regulato±³ function if there is,
as this study suggested.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS